UPDATE : Wednesday, September 18, 2019
상단여백
Prosecutors raid Sillajen over alleged use of undisclosed information
The prosecution on Wednesday carried out simultaneous raids on Sillajen'...
by Lee Han-soo  |  2019-08-29 11:27
라인
Antidiabetic DPP-4 inhibitors mark double-digit sales growth
Inhibitors of dipeptidyl peptidase 4 (DPP-4), used to treat diabetes, have ...
by Jeong Sae-im  |  2019-08-29 11:24
라인
Crystal Genomics' immunotherapy gets orphan drug status from US regulator
Crystal Genomics' CG-745, a molecular immunotherapy for pancreatic canc...
by Lee Han-soo  |  2019-08-28 17:44
라인
FDA OKs Boryung's P1 trial for immunotherapy candidate
Boryung Pharmaceutical said that the U.S. Food and Drug Administration has ...
by Lee Han-soo  |  2019-08-28 14:21
라인
Sales of new gastric acid blocker K-Cab top ₩10 billion
CJ HealthCare’s K-Cab Tab., the nation’s 30th novel drug, recorded over 10 ...
by Jeong Sae-im  |  2019-08-28 13:26
라인
Leo Pharma submits IND application for JW Pharmaceutical’s atopy treatment
JW Pharmaceutical said that Leo Pharma, a Denmark-based multinational pharm...
by Lee Han-soo  |  2019-08-28 13:24
라인
Pharmacists demand audit over Gliatilin’s insurance benefit
A pharmacists’ group demanded an audit against the Ministry of Health and W...
by Song Soo-youn  |  2019-08-27 16:01
라인
HLB to test rivoceranib+Lonsurf in colon cancer
HLB said it would test a combination therapy using rivoceranib with Lonsurf...
by Jeong Sae-im  |  2019-08-27 15:39
라인
Pharmaceutical sector’s job growth twice of all industries’ average
The pharmaceutical industry’s employment growth rate was eight times higher...
by Jeong Sae-im  |  2019-08-26 11:39
라인
Invossa still effective despite mislabeling, maker claims
Kolon Life Science said that U.S. orthopedic surgeons had published a resea...
by Lee Han-soo  |  2019-08-23 20:16
라인
Vivozon finishes P3 trial for nonnarcotic analgesics
Vivozon, a local biopharmaceutical company, said Friday that it has complet...
by Lee Han-soo  |  2019-08-23 16:03
라인
HLB wins FDA nod for P2 trial on rivoceranib in adenoid cystic carcinoma
HLB said Thursday it has obtained approval from the U.S. Food and Drug Admi...
by Jeong Sae-im  |  2019-08-23 15:02
라인
Ministry OKs P1 trial into Haim Bio’s metabolism anticancer drug
Haim Bio said that the Ministry of Food and Drug Safety has approved its in...
by Lee Han-soo  |  2019-08-23 13:53
라인
'Peptron's Parkinson's disease treatment blocks levodopa side effects'
Peptron said it has confirmed that PT320, a Parkinson's disease treatme...
by Lee Han-soo  |  2019-08-22 17:53
라인
‘Drug firm’s pick of doctor to attend conference overseas illegal’
Pharmaceutical companies’ support for physicians to attend academic confere...
by Kim Yun-mi  |  2019-08-22 15:45
라인
SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression
Sunosi (ingredient: solriamfetol), a treatment for narcolepsy developed by ...
by Lee Hye-seon  |  2019-08-22 15:37
라인
Tego Science’s diabetic foot ulcer treatment gets insurance benefit
Tego Science said that Kaloderm, a homologous cell-based drug, will receive...
by Lee Han-soo  |  2019-08-22 15:34
라인
Australia OKs Daewoong's P1 trial for idiopathic pulmonary fibrosis treatment
Daewoong Pharmaceutical said that it has won the go-ahead for its phase 1 c...
by Lee Han-soo  |  2019-08-22 14:36
라인
K-Hospital Fair 2019 opens 3-day show in Seoul
The K-Hospital Fair 2019 kicked off its three-day run in Seoul Wednesday. ...
by Lee Han-soo  |  2019-08-21 23:36
라인
Chong Kun Dang invests ₩5 billion in Biorchestra
Chong Kun Dang Holdings said that would invest 5 billion won ($4.1 million)...
by Lee Han-soo  |  2019-08-21 16:42
여백
여백
여백
Back to Top